Zobrazeno 1 - 10
of 38
pro vyhledávání: '"кардиоваскулярные заболевания"'
Autor:
A. M. Chaulin, D. V. Duplyakov
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 20, Iss 3 (2021)
Comorbidity is one of the most significant problems of modern healthcare. Numerous studies have analyzed the possible pathogenetic mechanisms and relationships between a wide variety of diseases. Cardiovascular (CVD) and pulmonary diseases, in partic
Externí odkaz:
https://doaj.org/article/ee38380ebf7741a6be7f8dd814d4c7c7
Publikováno v:
Кардиоваскулярная терапия и профилактика, Vol 18, Iss 2, Pp 70-75 (2019)
Aim. To study the structure of cardiovascular comorbidities, the quality of outpatient management and the structure of concomitant pathology in patients with cardiovascular continuum. To compare the obtained results with the results of the pilot stag
Externí odkaz:
https://doaj.org/article/8ab197c1ee7340b280fd4277f57d6a0a
Autor:
Т. A. Panafidina, Т. V. Popkova
Publikováno v:
Современная ревматология, Vol 12, Iss 4, Pp 4-8 (2018)
Systemic lupus erythematosus (SLE) is a systemic autoimmune disease of unknown etiology, which is characterized by the hyperproduction of organ-nonspecific autoantibodies to various components of the cell nucleus with the development of immunoinflamm
Externí odkaz:
https://doaj.org/article/870fb7e081ea4cc68c283bac5241cbb8
Publikováno v:
Архивъ внутренней медицины, Vol 7, Iss 5, Pp 371-377 (2017)
Objective: Obstructive sleep apnea (OSA) is associated with the high prevalence of cardiovascular diseases, and such disease manifestations as obesity, arterial hypertension (AH), violation of carbohydrate metabolism, dyslipidemia and endothelial dys
Externí odkaz:
https://doaj.org/article/b848fb901dcb4ffda32fa91b8f4a23cc
Autor:
M. S. Eliseev, O. V. Zhelyabina, E. I. Markelova, D. S. Novikova, S. A. Vladimirov, Yu. O. Korsakova, E. N. Aleksandrova, A. A. Novikov, E. L. Nasonov
Publikováno v:
Современная ревматология, Vol 10, Iss 1, Pp 7-14 (2016)
It is suggested that interleukin (IL)-1β inhibition may promote a reduction in the risk of cardiovascular diseases; however, the mechanism of this impact has not been adequately investigated.Objective: to evaluate the impact of canakinumab therapy o
Externí odkaz:
https://doaj.org/article/b520f047e9d44f0390b434c9f8f601d1
Autor:
R. I. Stryuk
Publikováno v:
Медицинский совет, Vol 0, Iss 9, Pp 100-105 (2015)
By now there is a substantial evidence on the role of magnesium deficiency, which can occur during pregnancy even in healthy women in case of its insufficient intake through food, in the deterioration of the clinical condition and obstetric complicat
Externí odkaz:
https://doaj.org/article/f61f9e1ff364417297a91fe456590c5d
Autor:
O.Yu. Filippova
Publikováno v:
HYPERTENSION; Том 13, № 4 (2020); 19-27
АРТЕРИАЛЬНАЯ ГИПЕРТЕНЗИЯ; Том 13, № 4 (2020); 19-27
АРТЕРІАЛЬНА ГІПЕРТЕНЗІЯ; Том 13, № 4 (2020); 19-27
АРТЕРИАЛЬНАЯ ГИПЕРТЕНЗИЯ; Том 13, № 4 (2020); 19-27
АРТЕРІАЛЬНА ГІПЕРТЕНЗІЯ; Том 13, № 4 (2020); 19-27
The article presents the results of the literature analysis to discuss the benefits and potential of alpha-lipoic acid and coenzyme Q10 (Ubiquinone) in patients with cardiovascular diseases, chronic diffuse liver diseases, diabetes mellitus and other
Autor:
S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, M. M. Lukyanov, N. N. Nikulina, A. V. Zagrebelny, A. N. Vorobyov, K. G. Pereverseva, E. A. Pravkina, A. D. Deev, E. Yu. Andreenko, A. I. Ershova, A. N. Meshkov, R. P. Myasnikov, S. E. Serdyuk, М. S. Kharlap
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 9, Iss 1, Pp 4-14 (2015)
Aim. To estimate risk factors and comorbidity structure, cardiovascular diseases outcomes, evaluate their diagnostics and treatment quality in real outpatient practice using a register of patients with arterial hypertension (HT), ischemic heart disea
Externí odkaz:
https://doaj.org/article/16267a25d1d041f4a138c8abaa48d7a8
Autor:
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 10, Iss 5, Pp 470-480 (2015)
Aim. To evaluate outcomes and risk of their occurrence in patients with atrial fibrillation (AF) within 12 months of follow-up in actual outpatient practice.Material and methods. A total of 3690 patients with AF, arterial hypertension (HT), ischemic
Externí odkaz:
https://doaj.org/article/e2f6d9dddc044abca636ca0b4b368f46
Autor:
M. M. Loukianov, S. A. Boytsov, S. S. Yakushin, S. Yu. Martsevich, A. N. Vorobyev, A. V. Zagrebelnyy, M. S. Kharlap, K. G. Pereverzeva, E. A. Pravkina, S. E. Serdyuk, A. D. Deev, E. N. Kudryashov
Publikováno v:
Рациональная фармакотерапия в кардиологии, Vol 10, Iss 4, Pp 366-377 (2015)
Aim. To study the structure of risk factors and associated cardiovascular and concomitant non-cardiac diseases in patients with atrial fibrillation (AF) on the base of the data of registry, and to estimate diagnostics and treatment quality in real ou
Externí odkaz:
https://doaj.org/article/c7c30fec99ab4e0e857b6a96994ad605